Range
2.46 - 2.59
Vol / Avg.
756.1K/905.1K
Div / Yield
-
52 Wk
0.58 - 4.26
Mkt Cap
437.5M
Payout Ratio
-
Open
2.55
P/E
42
EPS
-0.09
Shares
173.6M
Outstanding
173.6M
Total Float
101.6M
Benzinga - 5 days ago
Benzinga - Jun 8, 2021, 8:12AM
Benzinga - May 27, 2021, 8:07AM
Benzinga - May 14, 2021, 1:02PM
Benzinga - May 14, 2021, 8:10AM
Benzinga - Mar 31, 2021, 9:23AM
Benzinga - Mar 31, 2021, 8:11AM
Benzinga - Feb 17, 2021, 7:22AM
Benzinga - Feb 16, 2021, 4:39PM
Benzinga - Feb 16, 2021, 8:09AM
Benzinga - Feb 11, 2021, 8:19AM
Benzinga - Feb 9, 2021, 9:38AM
Benzinga - Feb 8, 2021, 11:06AM
load more
Sector: Health Care.Industry: Biotechnology
Outlook Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications.

Earnings

see more
Q3 2021Est.ActualSurprise
EPS
(EXPECTED)2021-08-13
REV
Q2 2021Est.ActualSurprise
EPS-0.090-0.090 0.0000
REV320.000K0-320.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
OTLKOutlook Therapeutics-3.08%437.5M

Outlook Therapeutics Frequently Asked Questions

Q

How do I buy Outlook Therapeutics (OTLK) stock?

A

You can purchase shares of Outlook Therapeutics (NASDAQ: OTLK) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Outlook Therapeutics's (OTLK) competitors?

A

Other companies in Outlook Therapeutics’s space includes: CytomX Therapeutics (NASDAQ:CTMX), OncoCyte (NASDAQ:OCX), Gritstone Bio (NASDAQ:GRTS), Viking Therapeutics (NASDAQ:VKTX) and Opthea (NASDAQ:OPT).

Q

What is the target price for Outlook Therapeutics (OTLK) stock?

A

The latest price target for Outlook Therapeutics (NASDAQ: OTLK) was reported by HC Wainwright & Co. on August 27, 2020. The analyst firm set a price target for 5.00 expecting OTLK to rise to within 12 months (a possible 98.41% upside). 2 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Outlook Therapeutics (OTLK)?

A

The stock price for Outlook Therapeutics (NASDAQ: OTLK) is $2.52 last updated Fri Jun 18 2021 20:00:04 GMT+0000 (Coordinated Universal Time).

Q

Does Outlook Therapeutics (OTLK) pay a dividend?

A

There are no upcoming dividends for Outlook Therapeutics.

Q

When is Outlook Therapeutics (NASDAQ:OTLK) reporting earnings?

A
Outlook Therapeutics’s Q3 earnings are confirmed for after-market on August 13, 2021.
Q

Is Outlook Therapeutics (OTLK) going to split?

A

There is no upcoming split for Outlook Therapeutics.

Q

What sector and industry does Outlook Therapeutics (OTLK) operate in?

A

Outlook Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.